Global Sarcopenia Treatment Market By Treatment Type (Medication, Vitamin/Dietary Supplements and Others), Route of Administration (Oral, Injectable and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Sarcopenia Treatment Market
Global Sarcopenia treatment market is rising gradually with a steady CAGR in the forecast period of 2019-2026. The growing prevalence of sarcopenia by increasing old age population and adoption of sedentary and unhealthy lifestyle is the major factor that contributes in the growth of global sarcopenia treatment market.
Market Definition: Global Sarcopenia Treatment Market
Sarcopenia is a progressive skeletal muscle disorder. It involves the loss of muscle mass and strength due to natural aging process. This condition affects the gait and overall ability of body to perform normal tasks. According to International Osteoporosis Foundation (IOF), the muscle loss starts from the age of 40. The major causes of sarcopenia could be sedentary lifestyle, malnutrition and unhealthy food intake. The increasing population of people aged more than 60 and the increasing cases of malnutrition worldwide are the major factors augmenting the market growth.
- Prevelance of geriatric population is expected to boost the market growth
- Increasing adoption of vitamins and dietary supplements among the ageing population for better treatment of this disorder also acts as a market driver The prevalence of sarcopenia is high among old age population drives the global sarcopenia treatment market
- Surging research and development activities for the treatment of sarcopenia also acts as a driver for this market
- Rising cases of malnutrition due to poor nutritional intake can also augment the growth of this market
- Lack of awareness among people regarding the muscle loss can act as a major restraint for this market
- Lack of skilled medical profession for the diagnosis of this disorder is also less; this factor can also restrict the growth of this market
- High cost of protein supplement and unavailability of sarcopenia treatment drugs can also impede the market growth
Segmentation: Global Sarcopenia Treatment Market
- Vitamin/ Dietary Supplements
By Route of Administration
By End Users
- Specialty Clinics
By Distribution Channels
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Key Developments in the Market:
- In April 2019. MYSURABLE S.R.L., has developed mioTest, a system based on effective and scientifically validated tools that identifies the risk of sarcopenia. The system can also assess muscle mass composition including functionality and level of hydration of muscles in a beneficial and non-invasive way
- In April 2019, PhaseBio Pharmaceuticals, Inc. licensed ImmunoForge, Co. Ltd. the global rights for PB1023, a recombinant GLP-1 analogue used for the treatment of patients with sarcopenia. ImmunoForge, Co. Ltd. is working on a pipeline for development of novel therapies for sarcopenia related diseases. PhaseBio Pharmaceuticals, Inc. will receive development milestone payments and royalty payments on the sales of the product by this licensed agreement
Global sarcopenia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sarcopenia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global sarcopenia treatment market are Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone, Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Nestlé, Mitacs, Sanofi, Bayer AG, Amway, Zydus Cadila, Eli Lilly and Company, Radius Health, Inc., MYSURABLE S.R.L., PhaseBio Pharmaceuticals, Inc among others.
Research Methodology: Global Sarcopenia Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
- Current and future of global sarcopenia treatment market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players